Roche Holding | ROG - EPS Earnings Per Share


Roche Holding reported CHF8.37 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025H2 Dec/2025 8.37 10.35 2.80 Jan/29
FY2025H1 Jun/2025 9.23 10.8 12682000000.0000 Jul/22
FY2024H2 Dec/2024 2.80 8.25 Jan/29
FY2024H1 Jun/2024 7.80 12353000000.0000 Jul/21
FY2023H2 Dec/2023 8.25 8.37 10432000000.0000 Feb/01




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alcon AG USD 0.85 0.07 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Fresenius EUR 0.82 0.04 Mar/2026
Fresenius Medical Care EUR 0.91 0.53 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
GRIFOLS EUR 0.14 0.11 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Orion EUR 0.66 1.19 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Philips EUR 0.23 0.37 Mar/2026
Recordati EUR 0.73 0 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025